Postoperative chemoradiotherapy for extrahepatic bile duct cancer

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 3, 2011, Pages 696-704

  Park, Jin Hong ^a   Choi, Eun Kyung ^a   Ahn, Seung Do ^a   Lee, Sang Wook ^a   Song, Si Yeol ^a   Yoon, Sang Min ^a   Kim, Young Seok ^a   Lee, Yu Sun ^a   Lee, Sung Gyu ^a   Hwang, Shin ^a   Lee, Young Joo ^a   Park, Kwang Min ^a   Kim, Tae Won ^b   Chang, Heung Moon ^b   Lee, Jae Lyun ^b   Kim, Jong Hoon ^a  

^a University of Ulsan   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

carbohydrate antigen 19 9; Extrahepatic bile duct cancer; postoperative chemoradiotherapy

Indexed keywords

5-FLUOROURACIL; ADJUVANT THERAPY; BILE DUCTS; CANCER PATIENTS; CHEMORADIOTHERAPY; CONCURRENT CHEMORADIOTHERAPY; CONCURRENT CHEMOTHERAPY; LOCOREGIONAL CONTROL; LOCOREGIONAL RECURRENCE; MEDIAN RADIATION; OVERALL SURVIVAL; OVERALL SURVIVAL RATES; PROGNOSTIC FACTORS; PROGRESSION FREE SURVIVAL; RESIDUAL TUMORS; THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY; UP PERIOD;

ANTIGENS; BODY FLUIDS; CARBOHYDRATES; CHEMOTHERAPY; CONCURRENCY CONTROL; DISEASES; DOSIMETRY; DUCTS; QUALITY ASSURANCE; THREE DIMENSIONAL;

RADIOTHERAPY;

CA 19-9 ANTIGEN;

ADULT; AGED; ARTICLE; BILE DUCT CANCER; CANCER CHEMOTHERAPY; CANCER SURGERY; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIATION DOSE; TREATMENT FAILURE;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; CA-19-9 ANTIGEN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 79551491912     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.12.031     Document Type: Article

References (24)

1. W.P. Longmire, M.S. McArthur, and E.A. Bastounis Carcinoma of the extrahepatic biliary tract Ann Surg 178 1973 333 345
2. A. Nakeeb, H.A. Pitt, and T.A. Sohn Cholangiocarcinoma: A spectrum of intrahepatic, perihilar, and distal tumors Ann Surg 224 1996 463 473 465
3. R. Reding, J.L. Buard, and G. Lebeau Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded): Results of the French Surgical Association Survey Ann Surg 213 1991 236 241
4. G. Kopelson, J. Galdabini, and A.L. Warshaw Patterns of failure after curative surgery for extra-hepatic biliary tract carcinoma: Implications for adjuvant therapy Int J Radiat Oncol Biol Phys 7 1981 413 417
5. W.R. Jarnagin, L. Ruo, and S.A. Little Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: Implications for adjuvant therapeutic strategies Cancer 98 2003 1689 1700
6. S.J. Wang, C.D. Fuller, and J.S. Kim Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer J Clin Oncol 26 2008 2112 2117
7. E.T. Shinohara, N. Mitra, and M. Guo Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas Int J Radiat Oncol Biol Phys 74 2009 1191 1198
8. H.A. Pitt, A. Nakeeb, and R.A. Abrams Perihilar cholangiocarcinoma: Postoperative radiotherapy does not improve survival Ann Surg 221 1995 788 797
9. T. Todoroki, K. Ohara, and T. Kawamoto Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma Int J Radiat Oncol Biol Phys 46 2000 581 587
10. S. Kim, S.W. Kim, and Y.J. Bang Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer Int J Radiat Oncol Biol Phys 54 2002 414 419
11. M.A. Hughes, D.A. Frassica, and C.J. Yeo Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct Int J Radiat Oncol Biol Phys 68 2007 178 182
12. M.A. Ben-David, K.A. Griffith, and E. Abu-Isa External-beam radiotherapy for localized extrahepatic cholangiocarcinoma Int J Radiat Oncol Biol Phys 66 2006 772 779
13. J.W. Nelson, A.P. Ghafoori, and C.G. Willett Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma Int J Radiat Oncol Biol Phys 72 2008 1495 1501
14. Y. Borghero, C.H. Crane, and J. Szklaruk Extrahepatic bile duct adenocarcinoma: Patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone Ann Surg Oncol 15 2008 3147 3156
15. Q. Cheng, X. Luo, and B. Zhang Predictive factors for prognosis of hilar cholangiocarcinoma: Postresection radiotherapy improves survival Eur J Surg Oncol 33 2007 202 207
16. M.F. Gerhards, T.M. van Gulik, and D. Gonzalez Gonzalez Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma World J Surg 27 2003 173 179
17. S.G. Lee, Y.J. Lee, and K.M. Park One hundred and eleven liver resections for hilar bile duct cancer J Hepatobiliary Pancreat Surg 7 2000 135 141
18. R. Schoenthaler, T.L. Phillips, and J. Castro Carcinoma of the extrahepatic bile ducts: The University of California at San Francisco experience Ann Surg 219 1994 267 274
19. D.E. Heron, D.E. Stein, and D.J. Eschelman Cholangiocarcinoma: The impact of tumor location and treatment strategy on outcome Am J Clin Oncol 26 2003 422 428
20. O. Nehls, M. Gregor, and B. Klump Serum and bile markers for cholangiocarcinoma Semin Liver Dis 24 2004 139 154
21. K.S. Goonetilleke, and A.K. Siriwardena Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer Eur J Surg Oncol 33 2007 266 270
22. A.C. Berger, M. Garcia Jr., and J.P. Hoffman Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: A prospective validation by RTOG 9704 J Clin Oncol 26 2008 5918 5922
23. National Institutes of Health NIH consensus conference: Adjuvant therapy for patients with colon and rectal cancer JAMA 264 1990 1444 1450
24. B.D. Minsky, M.F. Wesson, and J.G. Armstrong Combined modality therapy of extrahepatic biliary system cancer Int J Radiat Oncol Biol Phys 18 1990 1157 1163